1 / 29

PAH M&M – 6.20.13

PAH M&M – 6.20.13. Attending/CRNA: Parmet /Lamb Operation: Pituitary Adenoma Resection (via transpterygoid middle fossa skull base approach) Surgeons: Lee/Newman Complication: Internal carotid artery bleeding. Endoscopic Transpterygoid Approach. History.

palila
Download Presentation

PAH M&M – 6.20.13

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. PAH M&M – 6.20.13 Attending/CRNA: Parmet/Lamb Operation: Pituitary Adenoma Resection (via transpterygoid middle fossa skull base approach) Surgeons: Lee/Newman Complication: Internal carotid artery bleeding

  2. Endoscopic Transpterygoid Approach

  3. History • 64 yo AA female presents for resection of invasive pituitary macroadenoma • PSH: pituitary adenoma resection 2001, B/L TKR 2013 • PMH: HTN, GERD • Meds: Amlodipine, Atorvastatin, HCTZ • Allergies: NKDA • Vitals = 142/64, 84, 98% • 5’2”, 141#

  4. Pre-Op Labs Na 139, K 4.0, BUN 11, Creat 0.70, Glucose 152 Hgb 10.2, Hct 30, Platelets 185 INR 1.3

  5. Case Management • Smooth IV induction, 2 large bore IVs, A-line • Oral Rae ETT • TIVA with propofol/remifentanilgtts • Neuromonitoring • Supine position with bed rotated 90°

  6. Incident • Acute blood loss s/p insult to left internal carotid artery ~1L within 1min • Hgb decreased from 11.1 to 8.8 on istat • Abrupt change in BP 118/60  24/11 • Pulse ox dampened

  7. 21% of patients have an incomplete circle of willis

  8. Interventions • Unit of blood checked/infusing • Phenylephrine administered to support BP • BP  160/90 – NTG titrated to avoid HTN • Foley cath placed by surgeon to control bleeding • Remi/Propofol gtts increased for burst suppression • Rocuronium administered (MEPs lost but SSEPs/VEPs maintained) • 1gm Magnesium to increase seizure threshold • Normocarbia maintained • Hypothermia induced for cerebral protection

  9. Case Analysis Incident: “Brisk internal carotid artery bleeding” Patient Safety: A-line, IV access in place, Pt was T&C by anesthesia with 4units PRBC in room Communication: Bleeding verbalized by surgeon, confirmed by anesthesia witnessing severe hypotension, Anesthesia STAT called for additional support Health Care System: Transport to HUP via EmSTAR for IR

  10. Post-Op Status • Taken to IR for angio and coils for L ICA • PEA arrest s/p 24hrs cooling • Day 3: CSF leak repair, MRI shows small punctate stroke • Day 9: extubated, transferred to neuro step down, palsy of left CN 3 (oculomotor) and CN 6 (abducens), asa initiated for concern of stump emboli

  11. Current Literature Review • 1. Normocapnia • 2. Hypothermia • 3. Transfusion • 4. IHA vs. TIVA • 5. Glucose

  12. Basics Review • CBF = 50ml/100gm/min (750ml/min); 15-20% of CO • CBF maintained with a MAP of 50-150 • Current literature advocates for maintaining baseline MAP or MAP >80 • CBF decreases 3% per 1mmHg change in PaCO2 (20-60mmHg) • CPP = MAP – ICP or CVP (normal 70-100mmHg) • CMRO2 and CBF are coupled • CBF and PaCO2 are directly proportional between tensions of 20-60mmHg.

  13. Why Hypocapnia? • Hypocapnia widely used today……good or bad? • Monroe-Kellie Doctrine = fixed volume (80/12/8) • Used to lower ICP by decreasing CBF and CBV • accomplished by cerebral arterial vasoconstriction • Intracranial HTN causes secondary brain injury by: • Impairing cerebral perfusion • Brain herniation

  14. LuxuryPerfusion Luxury Perfusion thought to be reduced by hypocapnia – now concept of luxury perfusion is largely discredited – Why? CBF and CMRO2 have been found to be decreased after brain injury Regional CBF is markedly decreased particularly in 1st 24hrs Early hypocapnia may be harmful Only 30% of CBV located in arteries (only arteries respond to change in PaCO2) Decreasing CBF by 30% only translates to decrease of 7% in CBV Arterioles most sensitive to PaCO2 change, larger arteries least sensitive (ie: ICA) “Capacity for hypocapnia to decrease CBV is limited and achieved at a disproportionate cost to arterial CBF” (Curley, 2010, p. 1349)

  15. Concerns about Hypocapnia • 1. Causes cerebral hypoperfusion • 2. Worsens cerebral vasospasm (ie: SAH) • These 2 factors worsen outcome and impair CBF that may already be at risk • Injured area my be more responsive to CO2, therefore, hypocapnia may potentiate a secondary ischemic injury by diverting CBF from the injured area of the brain

  16. Hypocapnia and TBI Results in increased CMRO2 and prolongs seizure activity Increases lactate/O2 demand Causes regional cerebral ischemia Produces ischemic changes visualized on MRI PaCO2 <35mmHg does not improve outcome RCT compared PaCO2 of 25 v.s 35 Prolonged hyperventilation (>20min) worsens outcome Hypocapnia increases overall level AND variability of ICP Hypocapnia lasts 4hrs at most Rebound intracranial HTN occurs when normocapnia is restored – could potentially result in brainstem herniation Hypocapnia is ineffective/counterproductive in controlling ICP over time

  17. Hypocapnia and Stroke • Decreased PaCO2 = poor prognosis • Decreased PaCO2 thought to shunt blood to ischemic area of the brain, however, inverse steal phenomenon is now known not to occur

  18. Hypocapnia in Healthy Patients • Impairs healthy patients post-op x48hrs • Marked effect on older patients • PaCO2 <24mmHg = delayed rxn times for up to 6 days • PaCO2 <15mmHG = decreased basic psychomotor function • INCREASED PaCO2 during anesthesia enhances neurophysiologic performance postop • Decreased PaCO2 = decreases perfusion to heart, liver, GI • Affects myocardial O2 delivery, increases O2 demand, may result in dysrhythmias, decreases coronary blood flow

  19. Oxy-Hemoglobin Dissociation Curve

  20. Levels of Hypocapnia • Normocapnia = 36-45mmHg • Moderate Hypocapnia = 28-35mmHg • Temporarily improved cerebral autoregulation • Shown to be detrimental even for brief periods of 20min • Shown to produce critical reductions in regional brain tissue PaO2 in 20% of patients with TBI • Severe Hypocapnia = 23mmHg • Impairs autoregulation

  21. When to use hypocapnia? • Hypocapnia is still best way to reduce ICP acutely (ie: in the event of imminent brain herniation) • Also facilitates access and decrease brain bulk intraop • More severe and greater duration, the greater the potential for adverse outcome • Must weigh risks vs. benefit • Should we be advocating for the use of brain oxygenation monitors? • “frequently harmful and rarely, if ever, beneficial” (Curley, 2010, p. 1355)

  22. Hypothermia for Cerebral Protection • 32-35°C • Hypothermia: decreases CMR and CBF • CBF changes 5-7% per 1°C • Maintains BBB s/p ischemia,  metabolic demands, Constricts blood vessels =  cerebral blood volume, Inhibits inflammatory pathway • Mild hypothermia is safe but found to be ineffective as a neuroprotectant in the setting of neurosurgery (no benefit regarding M&M when compared to normothermia) • 2011: National Acute Brain Injury Study: Hypothermia II Trial – terminated prematurely d/t the “ineffectiveness of the intervention” • Sentiment supported by a 2012 cochrane review “Cooling for Cerebral Protection during Brain Surgery”

  23. HUP Neurocritical Care Hypothermia Protocol • Cool to 33°C using arctic sun pads • Indications: TBI, Large Hemispheric Ischemic Stroke, ICP, Hypoxic-Ischemic brain injury s/p cardiac arrest • Maintained 24-72hrs (re-eval by NSG attending Q24hrs) • Rewarmed over 12-24hrs

  24. Optimum Hgb for NSG • Low Hgb associated with poor neurological outcome and increased mortality • Anemia (<9g/dl) independent predictor of severe neurological impairment in SAH pts • Anemia resulted in decreased oxygen delivery resulting in detrimental hypoxic cell signaling pathways • Measure MetHb (marker for anemic stress) • Increasing MetHb levels are associated with poor outcomes and would signal need for prompt blood transfusion • Recommended that preop and intraopHgb levels be kept at 12g/dl preop and 9g/dl intraop in neurosurgical patients • This recommendation is in contention with TRICC (transfusion requirements in critical care) trial, which is not applicable to nsg pts who are more vulnerable to adverse neurological events

  25. Transfusion • PRBC transfusion associated with improved 30day survival • Improves brain tissue oxygenation in patients with TBI and SAH • As usual……any potential benefits must be weighed against risks of excessive or unnecessary blood transfusion

  26. IHA vs. TIVA • Barriers: Pharmacologic animal studies indicating one is superior to the other has not been translated to humans • No present RCTs assessing neuroprotection of pharmacological agents in pts undergoing intracranial surgery • Post Hoc study of 441 IHAST patients found TIVA did not impact odds of having improved neurological outcome • Limited data suggesting improved neuro outcome after IHA • IHA Pre/post-conditioning ischemic and traumatic pts = no benefit

  27. Glucose Control for NSG patients • 2001 – began use of Intensive Insulin Therapy (IIT), kept blood glucose (BG) within range of 80-110 • 3 fold increase for iatrogenic hypoglycemia and did not improve neurological outcome evaluated at 6mos • Retrospective study including 834 pts with SAH saw increased incidence of vasospasm (22 to 34%) • Hyperglycemia: • 178 pts with mean BG >140 on days 1-5 after SAH had worse neurological outcome at 1 year follow up • Two retrospective studies involving 1806 TBI pts showed worse neurological outcome with mean BG >118 and single episode BG >200 within first 10 days postop

  28. Optimal Glucose: “Normoglycemia” • NICE-SUGAR Trial (multicenter, multinational, RCT) • 6104 patients • Tight BG control (81-108) vs. conventional glucose control (144-180) • Tight BG group experienced higher mortality • Range of 140-180 is associated with lower 90day mortality • Also recommended by AACE • Intraoperative Hypothermia for Aneurysm Surgery Trial (IHAST) • Glucose levels >129-152 at time of clipping a ruptured cerebral aneurysm were associated with long term cognitive changes and neuro dysfunction

  29. References Beheiry, H.E. (2012). Protecting the brain during neurosurgical procedures: strategies that can work. Current Opinion in Anesthesiology, 25, 548-555. Bilotta, F., & Rosa, G. (2010). Glucose management in the neurosurgical patient: are we yet any closer? Current Opinion in Anesthesiology, 23, 539-543. Curley, G., Kavanaugh, B.P., & Laffey, J.G. (2010). Hypocapnia and the injured brain: More harm than benefit. Critical Care Medicine, 38, 1348-1359. Milani, W.R., Antibas, P.L., & Gilmar, F.P. (2012). Cooling for cerebral protection during brain surgery. The Cochrane Collaboration, 7, 1-39. Pasternak, J.J., & Lanier, W.L. (2013). Neuroanesthesiology Update. Journal of Neurosurgical Anesthesiology, 25, 98-134.

More Related